H. Niikura et al., EXPRESSION OF EPIDERMAL GROWTH FACTOR-RELATED PROTEINS AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN COMMON EPITHELIAL OVARIAN-TUMORS, International journal of gynecological pathology, 16(1), 1997, pp. 60-68
The biologic significance of epidermal growth factor (EGF)-related pro
teins and EGF receptor (EGFR) in the development and progression of hu
man ovarian carcinoma was studied in 17 ovarian cystadenomas, 6 mucino
us tumors of low malignant potential (LMP), and 25 invasive adenocarci
nomas by immunohistochemistry. Results were correlated with clinicopat
hologic features. We also examined immunoreactivity in five serous ade
nocarcinomas both before and after cisplatin chemotherapy. Amphireguli
n (AR) expression was observed only in mucinous tumors (4 of 8 cystade
nomas, 2 of 6 tumors of LMP, and 6 of 10 cystadenocarcinomas), but was
not detected in the serous tumors or clear cell adenocarcinomas. EGF,
cripto, and EGFR expression was significantly higher in mucinous cyst
adenocarcinomas than in mucinous cystadenomas or mucinous tumors of LM
P, Three of five specimens obtained at a second operation after chemot
herapy had moro intense or diffuse immunostaining for transforming gro
wth factor alpha (TGF-alpha) than the initial specimens did. Coexpress
ion of more than two of the EGF-related proteins or EGFR significantly
correlated with increased surgical stage in serous and clear cell car
cinoma. AR expression seems to correlate with mucinous differentiation
rather than with advanced stages of ovarian tumors. Our results indic
ate that expression of some EGF-related proteins is greater in certain
subtypes of ovarian carcinomas than in their benign counterparts and
that coexpression of these proteins is associated with advanced stage
in serous and clear cell carcinoma. Increased TGF-alpha expression may
also be related to ovarian tumor resistance to cisplatin chemotherapy
.